TMO vs PFE
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | PFE |
|---|---|---|
| Price | $700.22 | $28.89 |
| Market cap | $259.44B | $164.67B |
| P/E ratio | 36.9 | 41.3 |
| ROE | 13.38% | 4.47% |
| Profit margin | 14.94% | 6.34% |
| Revenue growth | 9.10% | -0.40% |
| Dividend yield | 0.27% | 5.95% |
| Beta | 0.84 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs PFE in plain English
- TMO is the bigger company — about 1.6× the market cap of PFE.
- TMO is cheaper on earnings (P/E 36.9 vs 41.3).
- TMO earns a higher return on equity (13% vs 4%).
- TMO is growing revenue faster (9% vs -0%).
- PFE has the higher dividend yield (5.95% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.